Cancer

Items 211-220 of 234

per page
Set Descending Direction
  1. Splitomicin
    CAS  5690-03-9
    AG-CR1-0088
    AG-CR1-0088-M0011 mg
    CHF 35.00
    AG-CR1-0088-M0055 mg
    CHF 60.00
    AG-CR1-0088-M02525 mg
    CHF 240.00
    Splitomicin
  2. SR3677
    CAS  1072959-67-1
    SYN-1083
    SYN-1083-M0011 mg
    CHF 142.00
    SYN-1083-M0055 mg
    CHF 220.00
    SYN-1083-M01010 mg
    CHF 298.00
    SYN-1083-M05050 mg
    CHF 1'078.00
    SYN-1083-M100100 mgINQ
    SR3677
  3. Sterigmatocystin
    CAS  10048-13-2
    BVT-0171
    BVT-0171-M0011 mg
    CHF 60.00
    BVT-0171-M0055 mg
    CHF 180.00
    Sterigmatocystin
  4. Stevioside . hydrate
    CAS  57817-89-7 (anhydrous)
    AG-CN2-0077
    AG-CN2-0077-M01010 mg
    CHF 80.00
    AG-CN2-0077-M05050 mg
    CHF 320.00
    Stevioside . hydrate
  5. Stigmasterol
    CAS  83-48-7
    AG-CN2-0412
    AG-CN2-0412-G0011 g
    CHF 60.00
    AG-CN2-0412-G0055 g
    CHF 240.00
    Stigmasterol
  6. Stigmasterol
    CAS  83-48-7
    CDX-S0267
    CDX-S0267-G0055 g
    CHF 129.00
    CDX-S0267-G01010 g
    CHF 231.00
    CDX-S0267-G02525 g
    CHF 530.00
    Stigmasterol
  7. Succinate [Succinic acid]
    CAS  110-15-6
    AG-CN2-0521
    AG-CN2-0521-G0011 g
    CHF 30.00
    AG-CN2-0521-G0055 g
    CHF 80.00
    Succinate [Succinic acid]
  8. Survodutide
    CAS  2805997-46-8
    AG-CP3-0046
    AG-CP3-0046-M0011 mg
    CHF 65.00
    AG-CP3-0046-M0055 mg
    CHF 230.00
    AG-CP3-0046-M02525 mg
    CHF 690.00

    BULK available!
    Research Use Only (RUO). NOT ALLOWED FOR USE IN HUMANS.

    Learn more about GLP-1 & GIP Receptor Agonists

    NEW Survodutide
  9. T0901317
    CAS  293754-55-9
    AG-CR1-2906
    AG-CR1-2906-M01010 mg
    CHF 40.00
    AG-CR1-2906-M05050 mg
    CHF 130.00
    T0901317
  10. Tanshinone I
    CAS  568-73-0
    CDX-T0417
    CDX-T0417-M0055 mg
    CHF 54.00
    CDX-T0417-M02525 mg
    CHF 217.00
    Tanshinone I

Items 211-220 of 234

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.